Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark.
J Infect. 2012 Jan;64(1):34-40. doi: 10.1016/j.jinf.2011.10.003. Epub 2011 Oct 21.
To determine the long-term mortality, the causes of death and the incidence of cancer in listeria meningitis patients.
Nationwide, population-based cohort study including all adult patients diagnosed with listeria meningitis from 1977 to 2006 and alive 1 year after diagnosis, and an age-and gender-matched, population control cohort. Kaplan-Meier tables, Cox regression analysis and cumulative incidence function were used as outcome analyses.
We identified 114 listeria meningitis patients and 1026 population controls. The adjusted mortality rate ratio (MRR) for listeria meningitis patients the first 5 years of follow-up was 2.35(95% confidence interval (CI) 1.60-3.45) thereafter the MRR was 0.93(95% CI: 0.56-1.55). Listeria meningitis patients had an increased risk of death due to cancer the first 5 years of follow-up, and in the same period patients above 50 years of age had a 2-fold increased risk of being diagnosed with cancer, thereafter the risks declined to that of the background population.
The long-term mortality in adult patients diagnosed with listeria meningitis was increased the first 5 years of follow-up, mainly due to death from cancer, thereafter the mortality did not differ from the background population. To improve survival this patient population should be meticulously screened for predisposing conditions, mainly underlying malignant diseases.
确定李斯特菌脑膜炎患者的长期死亡率、死亡原因和癌症发病率。
本研究为全国范围内基于人群的队列研究,纳入了 1977 年至 2006 年间所有被诊断为李斯特菌脑膜炎的成年患者,以及诊断后 1 年仍存活的患者,并将其与年龄和性别匹配的人群对照组进行比较。采用 Kaplan-Meier 表、Cox 回归分析和累积发病率函数进行结果分析。
我们共确定了 114 例李斯特菌脑膜炎患者和 1026 名人群对照。在随访的前 5 年,李斯特菌脑膜炎患者的校正死亡率比(MRR)为 2.35(95%置信区间[CI]为 1.60-3.45),此后 MRR 为 0.93(95%CI:0.56-1.55)。李斯特菌脑膜炎患者在随访的前 5 年有更高的死于癌症的风险,而且在同期 50 岁以上的患者中,癌症的诊断风险增加了两倍,此后风险降至与背景人群相同的水平。
诊断为李斯特菌脑膜炎的成年患者在随访的前 5 年的长期死亡率较高,主要是由于癌症导致的死亡,此后死亡率与背景人群无差异。为了提高生存率,应仔细筛查该患者人群的潜在疾病,主要是潜在的恶性疾病。